LIN vs SRZNW · P/E 34, rev $18.07B vs rev $10.7M
Linde plc Ordinary Shares (LIN) versus Surrozen Inc. Warrant (SRZNW) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Surrozen Inc. Warrant (SRZNW) is a biotechnology company listed on US.
Latest reported LIN revenue for 2026-06-30 was $18.07B. Net income was $3.79B. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported SRZNW revenue for 2024-12-31 was $10.7M. Net income was -$63.6M. SRZNW currently screens at market cap $0.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. SRZNW currently screens at market cap $0.
Not investment advice. Open the LIN and SRZNW stock pages for the full models.
Not investment advice.